Biotech and Life Sciences

SQI Diagnostics announces $3.5M insider led financing

Ted Liu

Cumberland Private Wealth Management, Clive J. Beddoe and Wilmot L. Matthews to lead SQI Diagnostics $3.5M private placement

Perimeter Medical Imaging secures new financing

Ted Liu

Perimeter Medical Imaging secures new financing led by Roadmap Capital. (photo credit: Perimeter Medical Imaging)

Fusion Pharmaceuticals secures US $25M Series A

Ted Liu

Fusion Pharmaceuticals raised US $25M in Series A from Johnson & Johnson Innovation – JJDC, Inc. HealthCap, TPG Biotech, Genesys Capital, FACIT (Fight Against Cancer Innovation Trust).

Appili Therapeutics receives $2.8M ACOA funding

Ted Liu

Appili Therapeutics awarded $2.8M from ACOA, having raised $8.23M in equity and grants from Innovacorp and Bloom Burton & Co. led Canadian and US private investor syndicate

Sierra Oncology announces public offering led by Jefferies

Ted Liu

Sierra Oncology, formerly ProNAi Therapeutics, to close public offering with Jefferies acting as the sole book-running manager

Solarvest secures $1M financing from Drashta Ventures

Ted Liu

Solarvest has secured $1M in financing from Drashta Ventures

Dr. Soon-Shiong exercises ProMetic warrants for $74.8M gain

Ted Liu

Dr. Patrick Soon-Shiong acquired 44,791,488 ProMetic Life Sciences share through exercise of warrants, generating $74.8M in profits.

Sirona Biochem completes $665K financing

Ted Liu

Sirona Biochem raised $665,360 by way of oversubscribed convertible note private placement.

Ironshore Pharmaceuticals secures US $200M financing

Ted Liu

Ironshore Pharmaceuticals & Development, a wholly owned subsidiary of Highland Therapeutics, raised $200M from Canadian and foreign investors.

VWR acquires SEASTAR CHEMICALS from AXYS Group

Ted Liu

VWR (NASDAQ: VWR) has acquired SEASTAR CHEMICALS Inc., a member of the AXYS Group. Madison Dearborn Partners, previously a controlling shareholder, owns 35% of VWR. (photo credit: SEASTAR)

AmorChem forms Corbin Therapeutics with USP15 spinout

Ted Liu

AmorChem has transferred USP15-Deubiquitinylation (Dub) drug discovery platform into a newly formed Corbin Therapeutics together with $1 million seed investment. (photo credit: AmorChem)

e@UBC Seed Fund invests in Microdermics

Ted Liu

Microdermics Inc., a Vancouver based hollow microneedle technology company, has closed a seed round of financing led by e@UBC Seed Fund. (photo credit: Microdermics)

Terramera secures additional Series B funding

Ted Liu

Terramera, an Ag-Bio Technology leader developing sustainable plant based pest and disease control solutions, has secured additional Series B add-on financing.

Fulcrum Capital Partners invests in Vitalus Nutrition

Ted Liu

Fulcrum Capital Partners Fund V has made an investment in Vitalus Nutrition to support the company growth. The investment is the sixth platform investment made by Fulcrum Capital Partners Fund V, a $344 million 2014 vintage fund.

Exact Imaging secures $21.5M Series C

Ted Liu

Exact Imaging has raised CDN $21.5M in Series C from Lumira Capital, Vesalius Biocapital, PMV (Participatiemaatschappij Vlaanderen), iGan Partners and others. The Series C includes conversion of bridge financing closed in April 2016.

Versant Ventures closes Fund VI in record time

Ted Liu

Versant Ventures has closed Versant Venture Capital VI, at its hard cap of US $400 million or CDN $538 million, and in a record time. Versant Venture Capital VI family of funds consists of a Delaware main fund and an Ontario parallel fund. Versant Ventures (photo credit: Versant)